nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—CHD1—lymphoid tissue—ulcerative colitis	0.00724	0.1	CbGeAlD
Epirubicin—AURKA—lymphoid tissue—ulcerative colitis	0.00584	0.0809	CbGeAlD
Epirubicin—AURKA—digestive system—ulcerative colitis	0.00577	0.0799	CbGeAlD
Epirubicin—YWHAG—FoxO family signaling—MST1—ulcerative colitis	0.00564	0.0261	CbGpPWpGaD
Epirubicin—YWHAG—smooth muscle tissue—ulcerative colitis	0.00561	0.0777	CbGeAlD
Epirubicin—CHD1—liver—ulcerative colitis	0.00533	0.0739	CbGeAlD
Epirubicin—YWHAG—Centrosome maturation—CEP72—ulcerative colitis	0.0052	0.0241	CbGpPWpGaD
Epirubicin—DHCR7—lymphoid tissue—ulcerative colitis	0.00488	0.0677	CbGeAlD
Epirubicin—UGT2B7—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.00487	0.0226	CbGpPWpGaD
Epirubicin—DHCR7—digestive system—ulcerative colitis	0.00482	0.0669	CbGeAlD
Epirubicin—YWHAG—Regulation of PLK1 Activity at G2/M Transition—CEP72—ulcerative colitis	0.00477	0.0221	CbGpPWpGaD
Epirubicin—AURKA—G2/M Transition—CEP72—ulcerative colitis	0.00473	0.0219	CbGpPWpGaD
Epirubicin—AURKA—Mitotic G2-G2/M phases—CEP72—ulcerative colitis	0.00466	0.0216	CbGpPWpGaD
Epirubicin—YWHAG—lymphoid tissue—ulcerative colitis	0.00448	0.0621	CbGeAlD
Epirubicin—YWHAG—digestive system—ulcerative colitis	0.00443	0.0614	CbGeAlD
Epirubicin—AURKA—Calcipotriol—Cholecalciferol—ulcerative colitis	0.00432	0.355	CbGdCrCtD
Epirubicin—AURKA—liver—ulcerative colitis	0.0043	0.0595	CbGeAlD
Epirubicin—YWHAG—a6b1 and a6b4 Integrin signaling—LAMB1—ulcerative colitis	0.00418	0.0194	CbGpPWpGaD
Epirubicin—PLA2G4A—smooth muscle tissue—ulcerative colitis	0.00418	0.058	CbGeAlD
Epirubicin—UGT2B7—digestive system—ulcerative colitis	0.004	0.0554	CbGeAlD
Epirubicin—YWHAG—Insulin-mediated glucose transport—CALM3—ulcerative colitis	0.00362	0.0168	CbGpPWpGaD
Epirubicin—DHCR7—liver—ulcerative colitis	0.00359	0.0498	CbGeAlD
Epirubicin—YWHAG—G2/M Transition—CEP72—ulcerative colitis	0.00358	0.0166	CbGpPWpGaD
Epirubicin—YWHAG—Mitotic G2-G2/M phases—CEP72—ulcerative colitis	0.00353	0.0164	CbGpPWpGaD
Epirubicin—YWHAG—liver—ulcerative colitis	0.0033	0.0457	CbGeAlD
Epirubicin—ABCC1—Sphingosine 1-phosphate (S1P) pathway—GNA12—ulcerative colitis	0.00326	0.0151	CbGpPWpGaD
Epirubicin—UGT2B7—liver—ulcerative colitis	0.00298	0.0413	CbGeAlD
Epirubicin—UGT2B7—NRF2 pathway—SLC39A11—ulcerative colitis	0.00298	0.0138	CbGpPWpGaD
Epirubicin—YWHAG—ErbB1 downstream signaling—ARPC2—ulcerative colitis	0.00297	0.0138	CbGpPWpGaD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—ARPC2—ulcerative colitis	0.00258	0.012	CbGpPWpGaD
Epirubicin—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGER4—ulcerative colitis	0.0024	0.0111	CbGpPWpGaD
Epirubicin—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGS1—ulcerative colitis	0.00237	0.011	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—TCF4—ulcerative colitis	0.00231	0.0107	CbGpPWpGaD
Epirubicin—YWHAG—Role of Calcineurin-dependent NFAT signaling in lymphocytes—CALM3—ulcerative colitis	0.0022	0.0102	CbGpPWpGaD
Epirubicin—PLA2G4A—Ca-dependent events—CALM3—ulcerative colitis	0.00213	0.00988	CbGpPWpGaD
Epirubicin—YWHAG—Translocation of GLUT4 to the plasma membrane—CALM3—ulcerative colitis	0.00199	0.00925	CbGpPWpGaD
Epirubicin—YWHAG—IL3-mediated signaling events—JAK2—ulcerative colitis	0.00173	0.00803	CbGpPWpGaD
Epirubicin—PLA2G4A—Endothelins—GNA12—ulcerative colitis	0.00169	0.00785	CbGpPWpGaD
Epirubicin—PLA2G4A—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.00157	0.00729	CbGpPWpGaD
Epirubicin—PLA2G4A—PLC beta mediated events—CALM3—ulcerative colitis	0.00157	0.00727	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—ARPC2—ulcerative colitis	0.00156	0.00725	CbGpPWpGaD
Epirubicin—PLA2G4A—Ca-dependent events—ADCY5—ulcerative colitis	0.00155	0.00717	CbGpPWpGaD
Epirubicin—PLA2G4A—G-protein mediated events—CALM3—ulcerative colitis	0.00154	0.00714	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—CEP72—ulcerative colitis	0.0015	0.00697	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—RUNX3—ulcerative colitis	0.00144	0.00667	CbGpPWpGaD
Epirubicin—ABCC1—liver—ulcerative colitis	0.00141	0.0195	CbGeAlD
Epirubicin—AURKA—Cell Cycle—CEP72—ulcerative colitis	0.00135	0.00624	CbGpPWpGaD
Epirubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—VDR—ulcerative colitis	0.00133	0.00618	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	0.00133	0.00616	CbGpPWpGaD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—PTPN2—ulcerative colitis	0.00132	0.0061	CbGpPWpGaD
Epirubicin—YWHAG—a6b1 and a6b4 Integrin signaling—CDH1—ulcerative colitis	0.00131	0.00608	CbGpPWpGaD
Epirubicin—YWHAG—ErbB1 downstream signaling—CALM3—ulcerative colitis	0.00129	0.00599	CbGpPWpGaD
Epirubicin—ABCC1—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.00126	0.00583	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	0.00115	0.00533	CbGpPWpGaD
Epirubicin—AURKA—Aurora A signaling—TP53—ulcerative colitis	0.00115	0.00531	CbGpPWpGaD
Epirubicin—ABCC1—ABC-family proteins mediated transport—ABCB1—ulcerative colitis	0.00114	0.00531	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CEP72—ulcerative colitis	0.00114	0.00529	CbGpPWpGaD
Epirubicin—PLA2G4A—PLC beta mediated events—ADCY5—ulcerative colitis	0.00114	0.00528	CbGpPWpGaD
Epirubicin—PLA2G4A—G-protein mediated events—ADCY5—ulcerative colitis	0.00112	0.00518	CbGpPWpGaD
Epirubicin—ABCC1—S1P1 pathway—PTGS2—ulcerative colitis	0.00104	0.00484	CbGpPWpGaD
Epirubicin—YWHAG—Activation of BH3-only proteins—TP53—ulcerative colitis	0.00103	0.00478	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CEP72—ulcerative colitis	0.00102	0.00473	CbGpPWpGaD
Epirubicin—YWHAG—Calcium Regulation in the Cardiac Cell—CALM3—ulcerative colitis	0.000976	0.00453	CbGpPWpGaD
Epirubicin—PLA2G4A—Opioid Signalling—CALM3—ulcerative colitis	0.000963	0.00446	CbGpPWpGaD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—CALM3—ulcerative colitis	0.000946	0.00438	CbGpPWpGaD
Epirubicin—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGS2—ulcerative colitis	0.000907	0.00421	CbGpPWpGaD
Epirubicin—TOP2A—Methyldopa—Mesalazine—ulcerative colitis	0.000889	0.073	CbGdCrCtD
Epirubicin—PLA2G4A—Endothelins—ADCY5—ulcerative colitis	0.000854	0.00396	CbGpPWpGaD
Epirubicin—YWHAG—Calcium Regulation in the Cardiac Cell—ADRB2—ulcerative colitis	0.000834	0.00387	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—ulcerative colitis	0.000828	0.00384	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PROCR—ulcerative colitis	0.000819	0.0038	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—MMP1—ulcerative colitis	0.000818	0.00379	CbGpPWpGaD
Epirubicin—YWHAG—Membrane Trafficking—CALM3—ulcerative colitis	0.000804	0.00373	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—PTGS2—ulcerative colitis	0.000802	0.00372	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—PTPN2—ulcerative colitis	0.000797	0.0037	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CEP72—ulcerative colitis	0.000797	0.0037	CbGpPWpGaD
Epirubicin—PLA2G4A—Endothelins—MMP1—ulcerative colitis	0.000756	0.0035	CbGpPWpGaD
Epirubicin—PLA2G4A—Dexamethasone—Budesonide—ulcerative colitis	0.000753	0.0619	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Budesonide—ulcerative colitis	0.000753	0.0619	CbGdCrCtD
Epirubicin—YWHAG—Intrinsic Pathway for Apoptosis—TP53—ulcerative colitis	0.000738	0.00342	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CEP72—ulcerative colitis	0.000713	0.00331	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—IL10—ulcerative colitis	0.00071	0.00329	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—CHP1—ulcerative colitis	0.000709	0.00329	CbGpPWpGaD
Epirubicin—YWHAG—Calcium Regulation in the Cardiac Cell—ADCY5—ulcerative colitis	0.000708	0.00328	CbGpPWpGaD
Epirubicin—PLA2G4A—Opioid Signalling—ADCY5—ulcerative colitis	0.000699	0.00324	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	0.000697	0.00323	CbGpPWpGaD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—ADCY5—ulcerative colitis	0.000686	0.00318	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CDH1—ulcerative colitis	0.000682	0.00316	CbGpPWpGaD
Epirubicin—YWHAG—LKB1 signaling events—TP53—ulcerative colitis	0.000668	0.0031	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	0.000664	0.00308	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—ulcerative colitis	0.000663	0.00307	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—CDH1—ulcerative colitis	0.000657	0.00305	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—GNA12—ulcerative colitis	0.00062	0.00287	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—DLD—ulcerative colitis	0.000612	0.00284	CbGpPWpGaD
Epirubicin—TOP2A—Gastric Cancer Network 2—TP53—ulcerative colitis	0.000607	0.00282	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	0.000604	0.0028	CbGpPWpGaD
Epirubicin—PLA2G4A—Arachidonic acid metabolism—PTGS2—ulcerative colitis	0.000603	0.0028	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—ulcerative colitis	0.000599	0.00278	CbGpPWpGaD
Epirubicin—UGT2B7—Biological oxidations—PTGS1—ulcerative colitis	0.000597	0.00277	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGF Pathway—STAT3—ulcerative colitis	0.000574	0.00266	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000566	0.00262	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—GHRL—ulcerative colitis	0.000555	0.00257	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—JAK2—ulcerative colitis	0.000545	0.00253	CbGpPWpGaD
Epirubicin—PLA2G4A—Endothelins—JAK2—ulcerative colitis	0.000533	0.00247	CbGpPWpGaD
Epirubicin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—RELA—ulcerative colitis	0.000529	0.00245	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—JAK2—ulcerative colitis	0.000513	0.00238	CbGpPWpGaD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—JAK2—ulcerative colitis	0.000508	0.00236	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—RELA—ulcerative colitis	0.000497	0.0023	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—CDH1—ulcerative colitis	0.000488	0.00226	CbGpPWpGaD
Epirubicin—ABCC1—Arachidonic acid metabolism—PTGS2—ulcerative colitis	0.000482	0.00223	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—ulcerative colitis	0.000477	0.00221	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—NFKB1—ulcerative colitis	0.000471	0.00218	CbGpPWpGaD
Epirubicin—Daunorubicin—ABCB1—ulcerative colitis	0.000467	0.552	CrCbGaD
Epirubicin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—NFKB1—ulcerative colitis	0.000446	0.00207	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	0.000435	0.00202	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—CALM3—ulcerative colitis	0.000431	0.002	CbGpPWpGaD
Epirubicin—YWHAG—ErbB1 downstream signaling—STAT3—ulcerative colitis	0.000429	0.00199	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—MMP9—ulcerative colitis	0.000424	0.00196	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—NFKB1—ulcerative colitis	0.000419	0.00194	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TGFB1—ulcerative colitis	0.000407	0.00189	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—STAT3—ulcerative colitis	0.0004	0.00185	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	0.000388	0.0018	CbGpPWpGaD
Epirubicin—PLA2G4A—Betamethasone—Hydrocortisone—ulcerative colitis	0.000386	0.0317	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Hydrocortisone—ulcerative colitis	0.000386	0.0317	CbGdCrCtD
Epirubicin—Doxorubicin—ABCB1—ulcerative colitis	0.000379	0.448	CrCbGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	0.000377	0.00175	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—STAT3—ulcerative colitis	0.000377	0.00175	CbGpPWpGaD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—IL1B—ulcerative colitis	0.000375	0.00174	CbGpPWpGaD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—STAT3—ulcerative colitis	0.000373	0.00173	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	0.000373	0.00173	CbGpPWpGaD
Epirubicin—PLA2G4A—Betamethasone—Methylprednisolone—ulcerative colitis	0.000364	0.0299	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Methylprednisolone—ulcerative colitis	0.000364	0.0299	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Betamethasone—ulcerative colitis	0.000358	0.0294	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Dexamethasone—ulcerative colitis	0.000358	0.0294	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Triamcinolone—ulcerative colitis	0.00035	0.0288	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Triamcinolone—ulcerative colitis	0.00035	0.0288	CbGdCrCtD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—NFKB1—ulcerative colitis	0.000349	0.00162	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	0.000348	0.00161	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TP53—ulcerative colitis	0.000335	0.00155	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.000334	0.00155	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.000334	0.00155	CbGpPWpGaD
Epirubicin—PLA2G4A—Dexamethasone—Prednisone—ulcerative colitis	0.000332	0.0273	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Prednisone—ulcerative colitis	0.000332	0.0273	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Prednisolone—ulcerative colitis	0.000324	0.0266	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Prednisolone—ulcerative colitis	0.000324	0.0266	CbGdCrCtD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	0.000324	0.0015	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—TP53—ulcerative colitis	0.000323	0.0015	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—GNA12—ulcerative colitis	0.00032	0.00148	CbGpPWpGaD
Epirubicin—TOP2A—Methyltestosterone—Hydrocortisone—ulcerative colitis	0.000316	0.026	CbGdCrCtD
Epirubicin—PLA2G4A—Hemostasis—ITGAL—ulcerative colitis	0.000314	0.00145	CbGpPWpGaD
Epirubicin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—ulcerative colitis	0.000309	0.00143	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—JAK2—ulcerative colitis	0.000308	0.00143	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PTGS1—ulcerative colitis	0.000296	0.00137	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	0.000291	0.00135	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—PPARG—ulcerative colitis	0.000291	0.00135	CbGpPWpGaD
Epirubicin—TOP2A—Methyltestosterone—Prednisone—ulcerative colitis	0.000272	0.0224	CbGdCrCtD
Epirubicin—YWHAG—Apoptosis—TNF—ulcerative colitis	0.000272	0.00126	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—TNF—ulcerative colitis	0.00027	0.00125	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—CALM3—ulcerative colitis	0.000266	0.00123	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—ulcerative colitis	0.000266	0.00123	CbGpPWpGaD
Epirubicin—TOP2A—Methyltestosterone—Prednisolone—ulcerative colitis	0.000266	0.0218	CbGdCrCtD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	0.000255	0.00118	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CHP1—ulcerative colitis	0.000245	0.00113	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CHP1—ulcerative colitis	0.00024	0.00111	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—TP53—ulcerative colitis	0.00024	0.00111	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	0.000238	0.0011	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CHP1—ulcerative colitis	0.000229	0.00106	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—STAT3—ulcerative colitis	0.000226	0.00105	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	0.000225	0.00104	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—CALM3—ulcerative colitis	0.000222	0.00103	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CXCR1—ulcerative colitis	0.000222	0.00103	CbGpPWpGaD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—IL6—ulcerative colitis	0.000219	0.00102	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—IL6—ulcerative colitis	0.000218	0.00101	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—DLD—ulcerative colitis	0.000211	0.000979	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—ALB—ulcerative colitis	0.00021	0.000973	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	0.000208	0.000964	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—DLD—ulcerative colitis	0.000207	0.00096	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—ABCB1—ulcerative colitis	0.000207	0.00096	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	0.000207	0.000958	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	0.000206	0.000957	CbGpPWpGaD
Epirubicin—TOP2A—Norethindrone—Hydrocortisone—ulcerative colitis	0.000206	0.0169	CbGdCrCtD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	0.000195	0.000905	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CCL20—ulcerative colitis	0.000195	0.000904	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—ADCY5—ulcerative colitis	0.000193	0.000896	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CHP1—ulcerative colitis	0.000192	0.000889	CbGpPWpGaD
Epirubicin—UGT2B7—NRF2 pathway—TGFB1—ulcerative colitis	0.000189	0.000874	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—GNA12—ulcerative colitis	0.000183	0.00085	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SEL1L—ulcerative colitis	0.000182	0.000843	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	0.00018	0.000833	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	0.000179	0.00083	CbGpPWpGaD
Epirubicin—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000178	0.000255	CcSEcCtD
Epirubicin—Myalgia—Methylprednisolone—ulcerative colitis	0.000178	0.000254	CcSEcCtD
Epirubicin—Arthralgia—Methylprednisolone—ulcerative colitis	0.000178	0.000254	CcSEcCtD
Epirubicin—Eye disorder—Prednisone—ulcerative colitis	0.000178	0.000254	CcSEcCtD
Epirubicin—Anxiety—Methylprednisolone—ulcerative colitis	0.000177	0.000253	CcSEcCtD
Epirubicin—Tachycardia—Hydrocortisone—ulcerative colitis	0.000177	0.000253	CcSEcCtD
Epirubicin—Rash—Azathioprine—ulcerative colitis	0.000177	0.000253	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000177	0.000253	CcSEcCtD
Epirubicin—Dermatitis—Azathioprine—ulcerative colitis	0.000176	0.000252	CcSEcCtD
Epirubicin—Flushing—Prednisone—ulcerative colitis	0.000176	0.000252	CcSEcCtD
Epirubicin—Skin disorder—Hydrocortisone—ulcerative colitis	0.000176	0.000252	CcSEcCtD
Epirubicin—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.000176	0.000252	CcSEcCtD
Epirubicin—Ill-defined disorder—Betamethasone—ulcerative colitis	0.000176	0.000252	CcSEcCtD
Epirubicin—Discomfort—Triamcinolone—ulcerative colitis	0.000176	0.000252	CcSEcCtD
Epirubicin—Discomfort—Methylprednisolone—ulcerative colitis	0.000176	0.000251	CcSEcCtD
Epirubicin—Headache—Azathioprine—ulcerative colitis	0.000175	0.000251	CcSEcCtD
Epirubicin—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000175	0.000251	CcSEcCtD
Epirubicin—Diarrhoea—Mesalazine—ulcerative colitis	0.000175	0.00025	CcSEcCtD
Epirubicin—Dry mouth—Triamcinolone—ulcerative colitis	0.000174	0.000249	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—CXCR2—ulcerative colitis	0.000174	0.000806	CbGpPWpGaD
Epirubicin—Anorexia—Hydrocortisone—ulcerative colitis	0.000173	0.000247	CcSEcCtD
Epirubicin—Angiopathy—Prednisone—ulcerative colitis	0.000172	0.000247	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	0.000172	0.000798	CbGpPWpGaD
Epirubicin—Confusional state—Methylprednisolone—ulcerative colitis	0.000172	0.000246	CcSEcCtD
Epirubicin—Immune system disorder—Prednisone—ulcerative colitis	0.000172	0.000246	CcSEcCtD
Epirubicin—Malaise—Betamethasone—ulcerative colitis	0.000171	0.000245	CcSEcCtD
Epirubicin—Malaise—Dexamethasone—ulcerative colitis	0.000171	0.000245	CcSEcCtD
Epirubicin—Oedema—Triamcinolone—ulcerative colitis	0.000171	0.000244	CcSEcCtD
Epirubicin—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000171	0.000244	CcSEcCtD
Epirubicin—Vertigo—Betamethasone—ulcerative colitis	0.000171	0.000244	CcSEcCtD
Epirubicin—Vertigo—Dexamethasone—ulcerative colitis	0.000171	0.000244	CcSEcCtD
Epirubicin—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.00017	0.000244	CcSEcCtD
Epirubicin—Syncope—Dexamethasone—ulcerative colitis	0.00017	0.000244	CcSEcCtD
Epirubicin—Syncope—Betamethasone—ulcerative colitis	0.00017	0.000244	CcSEcCtD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	0.00017	0.000789	CbGpPWpGaD
Epirubicin—Arrhythmia—Prednisone—ulcerative colitis	0.00017	0.000243	CcSEcCtD
Epirubicin—Infection—Triamcinolone—ulcerative colitis	0.00017	0.000243	CcSEcCtD
Epirubicin—Hypotension—Hydrocortisone—ulcerative colitis	0.00017	0.000243	CcSEcCtD
Epirubicin—Infection—Methylprednisolone—ulcerative colitis	0.000169	0.000242	CcSEcCtD
Epirubicin—Dizziness—Mesalazine—ulcerative colitis	0.000169	0.000241	CcSEcCtD
Epirubicin—Shock—Triamcinolone—ulcerative colitis	0.000168	0.00024	CcSEcCtD
Epirubicin—Insomnia—Prednisolone—ulcerative colitis	0.000168	0.00024	CcSEcCtD
Epirubicin—Alopecia—Prednisone—ulcerative colitis	0.000168	0.00024	CcSEcCtD
Epirubicin—Shock—Methylprednisolone—ulcerative colitis	0.000168	0.00024	CcSEcCtD
Epirubicin—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000167	0.000239	CcSEcCtD
Epirubicin—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000167	0.000239	CcSEcCtD
Epirubicin—Loss of consciousness—Betamethasone—ulcerative colitis	0.000167	0.000239	CcSEcCtD
Epirubicin—Paraesthesia—Prednisolone—ulcerative colitis	0.000167	0.000239	CcSEcCtD
Epirubicin—Tachycardia—Triamcinolone—ulcerative colitis	0.000167	0.000239	CcSEcCtD
Epirubicin—Mental disorder—Prednisone—ulcerative colitis	0.000166	0.000238	CcSEcCtD
Epirubicin—Nausea—Azathioprine—ulcerative colitis	0.000166	0.000238	CcSEcCtD
Epirubicin—Tachycardia—Methylprednisolone—ulcerative colitis	0.000166	0.000238	CcSEcCtD
Epirubicin—Skin disorder—Methylprednisolone—ulcerative colitis	0.000166	0.000237	CcSEcCtD
Epirubicin—ABCC1—Metabolism—DLD—ulcerative colitis	0.000166	0.000767	CbGpPWpGaD
Epirubicin—Erythema—Prednisone—ulcerative colitis	0.000165	0.000237	CcSEcCtD
Epirubicin—Malnutrition—Prednisone—ulcerative colitis	0.000165	0.000237	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000165	0.000236	CcSEcCtD
Epirubicin—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000165	0.000236	CcSEcCtD
Epirubicin—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000165	0.000236	CcSEcCtD
Epirubicin—Convulsion—Dexamethasone—ulcerative colitis	0.000165	0.000235	CcSEcCtD
Epirubicin—Convulsion—Betamethasone—ulcerative colitis	0.000165	0.000235	CcSEcCtD
Epirubicin—Insomnia—Hydrocortisone—ulcerative colitis	0.000164	0.000235	CcSEcCtD
Epirubicin—Hypertension—Dexamethasone—ulcerative colitis	0.000164	0.000235	CcSEcCtD
Epirubicin—Hypertension—Betamethasone—ulcerative colitis	0.000164	0.000235	CcSEcCtD
Epirubicin—TOP2A—Levonorgestrel—Hydrocortisone—ulcerative colitis	0.000164	0.0135	CbGdCrCtD
Epirubicin—PLA2G4A—Signaling by GPCR—CCR6—ulcerative colitis	0.000163	0.000758	CbGpPWpGaD
Epirubicin—ABCC1—Disease—LTF—ulcerative colitis	0.000163	0.000756	CbGpPWpGaD
Epirubicin—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000163	0.000233	CcSEcCtD
Epirubicin—Vomiting—Mesalazine—ulcerative colitis	0.000162	0.000232	CcSEcCtD
Epirubicin—Myalgia—Dexamethasone—ulcerative colitis	0.000162	0.000231	CcSEcCtD
Epirubicin—Myalgia—Betamethasone—ulcerative colitis	0.000162	0.000231	CcSEcCtD
Epirubicin—Anxiety—Dexamethasone—ulcerative colitis	0.000161	0.000231	CcSEcCtD
Epirubicin—Anxiety—Betamethasone—ulcerative colitis	0.000161	0.000231	CcSEcCtD
Epirubicin—Rash—Mesalazine—ulcerative colitis	0.000161	0.00023	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	0.000161	0.000746	CbGpPWpGaD
Epirubicin—Dermatitis—Mesalazine—ulcerative colitis	0.000161	0.00023	CcSEcCtD
Epirubicin—Headache—Mesalazine—ulcerative colitis	0.00016	0.000229	CcSEcCtD
Epirubicin—Discomfort—Dexamethasone—ulcerative colitis	0.00016	0.000229	CcSEcCtD
Epirubicin—Discomfort—Betamethasone—ulcerative colitis	0.00016	0.000229	CcSEcCtD
Epirubicin—Dyspepsia—Hydrocortisone—ulcerative colitis	0.00016	0.000228	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—SEL1L—ulcerative colitis	0.000159	0.000739	CbGpPWpGaD
Epirubicin—Hypotension—Methylprednisolone—ulcerative colitis	0.000159	0.000228	CcSEcCtD
Epirubicin—Pain—Prednisolone—ulcerative colitis	0.000159	0.000227	CcSEcCtD
Epirubicin—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000158	0.000226	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000157	0.000224	CcSEcCtD
Epirubicin—Fatigue—Hydrocortisone—ulcerative colitis	0.000156	0.000224	CcSEcCtD
Epirubicin—Vision blurred—Prednisone—ulcerative colitis	0.000156	0.000223	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000156	0.000223	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000155	0.000222	CcSEcCtD
Epirubicin—Pain—Hydrocortisone—ulcerative colitis	0.000155	0.000222	CcSEcCtD
Epirubicin—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.000155	0.000222	CcSEcCtD
Epirubicin—Anaphylactic shock—Betamethasone—ulcerative colitis	0.000155	0.000222	CcSEcCtD
Epirubicin—Oedema—Dexamethasone—ulcerative colitis	0.000155	0.000222	CcSEcCtD
Epirubicin—Oedema—Betamethasone—ulcerative colitis	0.000155	0.000222	CcSEcCtD
Epirubicin—Insomnia—Triamcinolone—ulcerative colitis	0.000155	0.000221	CcSEcCtD
Epirubicin—Insomnia—Methylprednisolone—ulcerative colitis	0.000154	0.000221	CcSEcCtD
Epirubicin—Infection—Betamethasone—ulcerative colitis	0.000154	0.00022	CcSEcCtD
Epirubicin—Infection—Dexamethasone—ulcerative colitis	0.000154	0.00022	CcSEcCtD
Epirubicin—Ill-defined disorder—Prednisone—ulcerative colitis	0.000153	0.00022	CcSEcCtD
Epirubicin—Paraesthesia—Triamcinolone—ulcerative colitis	0.000153	0.000219	CcSEcCtD
Epirubicin—Feeling abnormal—Prednisolone—ulcerative colitis	0.000153	0.000219	CcSEcCtD
Epirubicin—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000153	0.000219	CcSEcCtD
Epirubicin—Anaemia—Prednisone—ulcerative colitis	0.000153	0.000219	CcSEcCtD
Epirubicin—Shock—Dexamethasone—ulcerative colitis	0.000153	0.000218	CcSEcCtD
Epirubicin—Shock—Betamethasone—ulcerative colitis	0.000153	0.000218	CcSEcCtD
Epirubicin—Dyspnoea—Triamcinolone—ulcerative colitis	0.000152	0.000218	CcSEcCtD
Epirubicin—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000152	0.000217	CcSEcCtD
Epirubicin—Nervous system disorder—Betamethasone—ulcerative colitis	0.000152	0.000217	CcSEcCtD
Epirubicin—Agitation—Prednisone—ulcerative colitis	0.000152	0.000217	CcSEcCtD
Epirubicin—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000152	0.000217	CcSEcCtD
Epirubicin—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000152	0.000217	CcSEcCtD
Epirubicin—Nausea—Mesalazine—ulcerative colitis	0.000152	0.000217	CcSEcCtD
Epirubicin—Tachycardia—Dexamethasone—ulcerative colitis	0.000151	0.000216	CcSEcCtD
Epirubicin—Tachycardia—Betamethasone—ulcerative colitis	0.000151	0.000216	CcSEcCtD
Epirubicin—Dyspepsia—Triamcinolone—ulcerative colitis	0.00015	0.000215	CcSEcCtD
Epirubicin—Dyspepsia—Methylprednisolone—ulcerative colitis	0.00015	0.000215	CcSEcCtD
Epirubicin—Hyperhidrosis—Betamethasone—ulcerative colitis	0.00015	0.000214	CcSEcCtD
Epirubicin—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.00015	0.000214	CcSEcCtD
Epirubicin—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.00015	0.000214	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	0.000149	0.000692	CbGpPWpGaD
Epirubicin—Malaise—Prednisone—ulcerative colitis	0.000149	0.000213	CcSEcCtD
Epirubicin—Vertigo—Prednisone—ulcerative colitis	0.000149	0.000213	CcSEcCtD
Epirubicin—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000148	0.000212	CcSEcCtD
Epirubicin—Syncope—Prednisone—ulcerative colitis	0.000148	0.000212	CcSEcCtD
Epirubicin—Anorexia—Dexamethasone—ulcerative colitis	0.000148	0.000211	CcSEcCtD
Epirubicin—Anorexia—Betamethasone—ulcerative colitis	0.000148	0.000211	CcSEcCtD
Epirubicin—Urticaria—Prednisolone—ulcerative colitis	0.000148	0.000211	CcSEcCtD
Epirubicin—Fatigue—Triamcinolone—ulcerative colitis	0.000147	0.000211	CcSEcCtD
Epirubicin—Fatigue—Methylprednisolone—ulcerative colitis	0.000147	0.00021	CcSEcCtD
Epirubicin—Pain—Triamcinolone—ulcerative colitis	0.000146	0.000209	CcSEcCtD
Epirubicin—Loss of consciousness—Prednisone—ulcerative colitis	0.000145	0.000208	CcSEcCtD
Epirubicin—Hypotension—Betamethasone—ulcerative colitis	0.000145	0.000207	CcSEcCtD
Epirubicin—Hypotension—Dexamethasone—ulcerative colitis	0.000145	0.000207	CcSEcCtD
Epirubicin—Urticaria—Hydrocortisone—ulcerative colitis	0.000144	0.000206	CcSEcCtD
Epirubicin—DHCR7—Metabolism—PPARG—ulcerative colitis	0.000144	0.000668	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PTGER4—ulcerative colitis	0.000144	0.000667	CbGpPWpGaD
Epirubicin—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000143	0.000205	CcSEcCtD
Epirubicin—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000143	0.000205	CcSEcCtD
Epirubicin—Convulsion—Prednisone—ulcerative colitis	0.000143	0.000205	CcSEcCtD
Epirubicin—Hypertension—Prednisone—ulcerative colitis	0.000143	0.000204	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—MMP1—ulcerative colitis	0.000143	0.000662	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	0.000142	0.000657	CbGpPWpGaD
Epirubicin—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000141	0.000202	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000141	0.000202	CcSEcCtD
Epirubicin—Arthralgia—Prednisone—ulcerative colitis	0.000141	0.000201	CcSEcCtD
Epirubicin—Myalgia—Prednisone—ulcerative colitis	0.000141	0.000201	CcSEcCtD
Epirubicin—Feeling abnormal—Triamcinolone—ulcerative colitis	0.000141	0.000201	CcSEcCtD
Epirubicin—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.00014	0.000201	CcSEcCtD
Epirubicin—Anxiety—Prednisone—ulcerative colitis	0.00014	0.000201	CcSEcCtD
Epirubicin—Insomnia—Dexamethasone—ulcerative colitis	0.00014	0.000201	CcSEcCtD
Epirubicin—Insomnia—Betamethasone—ulcerative colitis	0.00014	0.000201	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.00014	0.0002	CcSEcCtD
Epirubicin—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000139	0.000199	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	0.000139	0.000646	CbGpPWpGaD
Epirubicin—Paraesthesia—Dexamethasone—ulcerative colitis	0.000139	0.000199	CcSEcCtD
Epirubicin—Paraesthesia—Betamethasone—ulcerative colitis	0.000139	0.000199	CcSEcCtD
Epirubicin—Discomfort—Prednisone—ulcerative colitis	0.000139	0.000199	CcSEcCtD
Epirubicin—Hypersensitivity—Prednisolone—ulcerative colitis	0.000137	0.000196	CcSEcCtD
Epirubicin—Dyspepsia—Dexamethasone—ulcerative colitis	0.000136	0.000195	CcSEcCtD
Epirubicin—Dyspepsia—Betamethasone—ulcerative colitis	0.000136	0.000195	CcSEcCtD
Epirubicin—TOP2A—Circadian rythm related genes—TP53—ulcerative colitis	0.000136	0.000631	CbGpPWpGaD
Epirubicin—Urticaria—Triamcinolone—ulcerative colitis	0.000136	0.000194	CcSEcCtD
Epirubicin—Urticaria—Methylprednisolone—ulcerative colitis	0.000135	0.000194	CcSEcCtD
Epirubicin—Body temperature increased—Triamcinolone—ulcerative colitis	0.000135	0.000193	CcSEcCtD
Epirubicin—Oedema—Prednisone—ulcerative colitis	0.000135	0.000193	CcSEcCtD
Epirubicin—Anaphylactic shock—Prednisone—ulcerative colitis	0.000135	0.000193	CcSEcCtD
Epirubicin—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000135	0.000193	CcSEcCtD
Epirubicin—Decreased appetite—Dexamethasone—ulcerative colitis	0.000135	0.000193	CcSEcCtD
Epirubicin—Decreased appetite—Betamethasone—ulcerative colitis	0.000135	0.000193	CcSEcCtD
Epirubicin—Infection—Prednisone—ulcerative colitis	0.000134	0.000192	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000134	0.000191	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000134	0.000191	CcSEcCtD
Epirubicin—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000134	0.000191	CcSEcCtD
Epirubicin—Fatigue—Dexamethasone—ulcerative colitis	0.000134	0.000191	CcSEcCtD
Epirubicin—Fatigue—Betamethasone—ulcerative colitis	0.000134	0.000191	CcSEcCtD
Epirubicin—Shock—Prednisone—ulcerative colitis	0.000133	0.00019	CcSEcCtD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	0.000133	0.000615	CbGpPWpGaD
Epirubicin—Pain—Dexamethasone—ulcerative colitis	0.000133	0.00019	CcSEcCtD
Epirubicin—Pain—Betamethasone—ulcerative colitis	0.000133	0.00019	CcSEcCtD
Epirubicin—Nervous system disorder—Prednisone—ulcerative colitis	0.000132	0.000189	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—GHRL—ulcerative colitis	0.000132	0.000611	CbGpPWpGaD
Epirubicin—Tachycardia—Prednisone—ulcerative colitis	0.000132	0.000188	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—CXCR1—ulcerative colitis	0.000131	0.000609	CbGpPWpGaD
Epirubicin—Skin disorder—Prednisone—ulcerative colitis	0.000131	0.000188	CcSEcCtD
Epirubicin—Hyperhidrosis—Prednisone—ulcerative colitis	0.000131	0.000187	CcSEcCtD
Epirubicin—Asthenia—Hydrocortisone—ulcerative colitis	0.00013	0.000186	CcSEcCtD
Epirubicin—DHCR7—Metabolism—ALB—ulcerative colitis	0.00013	0.000601	CbGpPWpGaD
Epirubicin—Anorexia—Prednisone—ulcerative colitis	0.000129	0.000184	CcSEcCtD
Epirubicin—Pruritus—Hydrocortisone—ulcerative colitis	0.000128	0.000184	CcSEcCtD
Epirubicin—Feeling abnormal—Dexamethasone—ulcerative colitis	0.000128	0.000183	CcSEcCtD
Epirubicin—Feeling abnormal—Betamethasone—ulcerative colitis	0.000128	0.000183	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—CALM3—ulcerative colitis	0.000128	0.000592	CbGpPWpGaD
Epirubicin—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000127	0.000181	CcSEcCtD
Epirubicin—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000127	0.000181	CcSEcCtD
Epirubicin—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000126	0.00018	CcSEcCtD
Epirubicin—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000126	0.00018	CcSEcCtD
Epirubicin—TOP2A—Circadian rythm related genes—IL6—ulcerative colitis	0.000125	0.000578	CbGpPWpGaD
Epirubicin—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000124	0.000178	CcSEcCtD
Epirubicin—Urticaria—Betamethasone—ulcerative colitis	0.000123	0.000176	CcSEcCtD
Epirubicin—Urticaria—Dexamethasone—ulcerative colitis	0.000123	0.000176	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000123	0.000176	CcSEcCtD
Epirubicin—Dizziness—Prednisolone—ulcerative colitis	0.000123	0.000176	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	0.000123	0.000569	CbGpPWpGaD
Epirubicin—Asthenia—Triamcinolone—ulcerative colitis	0.000123	0.000175	CcSEcCtD
Epirubicin—Body temperature increased—Betamethasone—ulcerative colitis	0.000123	0.000175	CcSEcCtD
Epirubicin—Abdominal pain—Dexamethasone—ulcerative colitis	0.000123	0.000175	CcSEcCtD
Epirubicin—Abdominal pain—Betamethasone—ulcerative colitis	0.000123	0.000175	CcSEcCtD
Epirubicin—Body temperature increased—Dexamethasone—ulcerative colitis	0.000123	0.000175	CcSEcCtD
Epirubicin—Asthenia—Methylprednisolone—ulcerative colitis	0.000122	0.000175	CcSEcCtD
Epirubicin—Insomnia—Prednisone—ulcerative colitis	0.000122	0.000175	CcSEcCtD
Epirubicin—Paraesthesia—Prednisone—ulcerative colitis	0.000121	0.000173	CcSEcCtD
Epirubicin—Pruritus—Triamcinolone—ulcerative colitis	0.000121	0.000173	CcSEcCtD
Epirubicin—Pruritus—Methylprednisolone—ulcerative colitis	0.000121	0.000173	CcSEcCtD
Epirubicin—Dizziness—Hydrocortisone—ulcerative colitis	0.00012	0.000172	CcSEcCtD
Epirubicin—ABCC1—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	0.00012	0.000555	CbGpPWpGaD
Epirubicin—Dyspepsia—Prednisone—ulcerative colitis	0.000119	0.00017	CcSEcCtD
Epirubicin—Decreased appetite—Prednisone—ulcerative colitis	0.000117	0.000168	CcSEcCtD
Epirubicin—Rash—Prednisolone—ulcerative colitis	0.000117	0.000168	CcSEcCtD
Epirubicin—Dermatitis—Prednisolone—ulcerative colitis	0.000117	0.000167	CcSEcCtD
Epirubicin—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000117	0.000167	CcSEcCtD
Epirubicin—Fatigue—Prednisone—ulcerative colitis	0.000116	0.000166	CcSEcCtD
Epirubicin—Headache—Prednisolone—ulcerative colitis	0.000116	0.000166	CcSEcCtD
Epirubicin—ABCC1—Disease—SLC11A1—ulcerative colitis	0.000116	0.000539	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—TP53—ulcerative colitis	0.000116	0.000537	CbGpPWpGaD
Epirubicin—Constipation—Prednisone—ulcerative colitis	0.000115	0.000165	CcSEcCtD
Epirubicin—Vomiting—Hydrocortisone—ulcerative colitis	0.000115	0.000165	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—CCL20—ulcerative colitis	0.000115	0.000534	CbGpPWpGaD
Epirubicin—Rash—Hydrocortisone—ulcerative colitis	0.000114	0.000164	CcSEcCtD
Epirubicin—Dermatitis—Hydrocortisone—ulcerative colitis	0.000114	0.000163	CcSEcCtD
Epirubicin—Headache—Hydrocortisone—ulcerative colitis	0.000114	0.000163	CcSEcCtD
Epirubicin—DHCR7—Metabolism—PTGS2—ulcerative colitis	0.000113	0.000526	CbGpPWpGaD
Epirubicin—Dizziness—Triamcinolone—ulcerative colitis	0.000113	0.000162	CcSEcCtD
Epirubicin—Dizziness—Methylprednisolone—ulcerative colitis	0.000113	0.000161	CcSEcCtD
Epirubicin—ABCC1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	0.000112	0.000517	CbGpPWpGaD
Epirubicin—Feeling abnormal—Prednisone—ulcerative colitis	0.000111	0.000159	CcSEcCtD
Epirubicin—Asthenia—Betamethasone—ulcerative colitis	0.000111	0.000159	CcSEcCtD
Epirubicin—Asthenia—Dexamethasone—ulcerative colitis	0.000111	0.000159	CcSEcCtD
Epirubicin—Gastrointestinal pain—Prednisone—ulcerative colitis	0.00011	0.000158	CcSEcCtD
Epirubicin—Nausea—Prednisolone—ulcerative colitis	0.00011	0.000158	CcSEcCtD
Epirubicin—Pruritus—Betamethasone—ulcerative colitis	0.00011	0.000157	CcSEcCtD
Epirubicin—Pruritus—Dexamethasone—ulcerative colitis	0.00011	0.000157	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	0.00011	0.000508	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—ADRB2—ulcerative colitis	0.000109	0.000506	CbGpPWpGaD
Epirubicin—Vomiting—Triamcinolone—ulcerative colitis	0.000109	0.000155	CcSEcCtD
Epirubicin—Vomiting—Methylprednisolone—ulcerative colitis	0.000108	0.000155	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—GNA12—ulcerative colitis	0.000108	0.000502	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—ALB—ulcerative colitis	0.000108	0.000502	CbGpPWpGaD
Epirubicin—Nausea—Hydrocortisone—ulcerative colitis	0.000108	0.000154	CcSEcCtD
Epirubicin—Rash—Triamcinolone—ulcerative colitis	0.000108	0.000154	CcSEcCtD
Epirubicin—Dermatitis—Triamcinolone—ulcerative colitis	0.000108	0.000154	CcSEcCtD
Epirubicin—Rash—Methylprednisolone—ulcerative colitis	0.000107	0.000154	CcSEcCtD
Epirubicin—Dermatitis—Methylprednisolone—ulcerative colitis	0.000107	0.000154	CcSEcCtD
Epirubicin—Urticaria—Prednisone—ulcerative colitis	0.000107	0.000153	CcSEcCtD
Epirubicin—Headache—Triamcinolone—ulcerative colitis	0.000107	0.000153	CcSEcCtD
Epirubicin—Headache—Methylprednisolone—ulcerative colitis	0.000107	0.000153	CcSEcCtD
Epirubicin—Body temperature increased—Prednisone—ulcerative colitis	0.000107	0.000153	CcSEcCtD
Epirubicin—Abdominal pain—Prednisone—ulcerative colitis	0.000107	0.000153	CcSEcCtD
Epirubicin—Diarrhoea—Dexamethasone—ulcerative colitis	0.000106	0.000152	CcSEcCtD
Epirubicin—Diarrhoea—Betamethasone—ulcerative colitis	0.000106	0.000152	CcSEcCtD
Epirubicin—ABCC1—Disease—MAML2—ulcerative colitis	0.000104	0.000484	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCR2—ulcerative colitis	0.000103	0.000476	CbGpPWpGaD
Epirubicin—Dizziness—Dexamethasone—ulcerative colitis	0.000103	0.000147	CcSEcCtD
Epirubicin—Dizziness—Betamethasone—ulcerative colitis	0.000103	0.000147	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—PTGS1—ulcerative colitis	0.000102	0.000473	CbGpPWpGaD
Epirubicin—Nausea—Triamcinolone—ulcerative colitis	0.000101	0.000145	CcSEcCtD
Epirubicin—Nausea—Methylprednisolone—ulcerative colitis	0.000101	0.000145	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—JAK2—ulcerative colitis	0.000101	0.000466	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PTGS1—ulcerative colitis	0.0001	0.000464	CbGpPWpGaD
Epirubicin—Hypersensitivity—Prednisone—ulcerative colitis	9.95e-05	0.000142	CcSEcCtD
Epirubicin—Vomiting—Betamethasone—ulcerative colitis	9.86e-05	0.000141	CcSEcCtD
Epirubicin—Vomiting—Dexamethasone—ulcerative colitis	9.86e-05	0.000141	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	9.85e-05	0.000457	CbGpPWpGaD
Epirubicin—Rash—Dexamethasone—ulcerative colitis	9.77e-05	0.00014	CcSEcCtD
Epirubicin—Rash—Betamethasone—ulcerative colitis	9.77e-05	0.00014	CcSEcCtD
Epirubicin—Dermatitis—Dexamethasone—ulcerative colitis	9.77e-05	0.00014	CcSEcCtD
Epirubicin—Dermatitis—Betamethasone—ulcerative colitis	9.77e-05	0.00014	CcSEcCtD
Epirubicin—Headache—Dexamethasone—ulcerative colitis	9.71e-05	0.000139	CcSEcCtD
Epirubicin—Headache—Betamethasone—ulcerative colitis	9.71e-05	0.000139	CcSEcCtD
Epirubicin—Asthenia—Prednisone—ulcerative colitis	9.69e-05	0.000139	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—CCR6—ulcerative colitis	9.66e-05	0.000448	CbGpPWpGaD
Epirubicin—Pruritus—Prednisone—ulcerative colitis	9.55e-05	0.000137	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—ADCY5—ulcerative colitis	9.26e-05	0.000429	CbGpPWpGaD
Epirubicin—Diarrhoea—Prednisone—ulcerative colitis	9.24e-05	0.000132	CcSEcCtD
Epirubicin—Nausea—Betamethasone—ulcerative colitis	9.21e-05	0.000132	CcSEcCtD
Epirubicin—Nausea—Dexamethasone—ulcerative colitis	9.21e-05	0.000132	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—CALM3—ulcerative colitis	9.19e-05	0.000426	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MAML2—ulcerative colitis	9.16e-05	0.000424	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CALM3—ulcerative colitis	9.02e-05	0.000418	CbGpPWpGaD
Epirubicin—Dizziness—Prednisone—ulcerative colitis	8.93e-05	0.000128	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle—TP53—ulcerative colitis	8.77e-05	0.000407	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—IL2—ulcerative colitis	8.77e-05	0.000407	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	8.75e-05	0.000406	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	8.62e-05	0.000399	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CALM3—ulcerative colitis	8.6e-05	0.000399	CbGpPWpGaD
Epirubicin—Vomiting—Prednisone—ulcerative colitis	8.58e-05	0.000123	CcSEcCtD
Epirubicin—Rash—Prednisone—ulcerative colitis	8.51e-05	0.000122	CcSEcCtD
Epirubicin—Dermatitis—Prednisone—ulcerative colitis	8.5e-05	0.000122	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—PTGER4—ulcerative colitis	8.5e-05	0.000394	CbGpPWpGaD
Epirubicin—Headache—Prednisone—ulcerative colitis	8.46e-05	0.000121	CcSEcCtD
Epirubicin—Nausea—Prednisone—ulcerative colitis	8.02e-05	0.000115	CcSEcCtD
Epirubicin—ABCC1—Metabolism—PTGS1—ulcerative colitis	8e-05	0.000371	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	7.87e-05	0.000365	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GHRL—ulcerative colitis	7.78e-05	0.000361	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CALM3—ulcerative colitis	7.54e-05	0.00035	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—ALB—ulcerative colitis	7.48e-05	0.000347	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RIPK2—ulcerative colitis	7.43e-05	0.000344	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CALM3—ulcerative colitis	7.2e-05	0.000334	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ABCB1—ulcerative colitis	7.15e-05	0.000331	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ABCB1—ulcerative colitis	7.01e-05	0.000325	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	6.88e-05	0.000319	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TGFB1—ulcerative colitis	6.84e-05	0.000317	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ADCY5—ulcerative colitis	6.67e-05	0.000309	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ADCY5—ulcerative colitis	6.54e-05	0.000303	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ADRB2—ulcerative colitis	6.44e-05	0.000299	CbGpPWpGaD
Epirubicin—ABCC1—Disease—ADCY5—ulcerative colitis	6.24e-05	0.000289	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—TP53—ulcerative colitis	6.14e-05	0.000285	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—JAK2—ulcerative colitis	5.77e-05	0.000268	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TP53—ulcerative colitis	5.63e-05	0.000261	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ABCB1—ulcerative colitis	5.6e-05	0.00026	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ADCY5—ulcerative colitis	5.47e-05	0.000254	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CXCL8—ulcerative colitis	5.27e-05	0.000244	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ADCY5—ulcerative colitis	5.23e-05	0.000242	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL2—ulcerative colitis	5.03e-05	0.000233	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PPARG—ulcerative colitis	4.97e-05	0.000231	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PPARG—ulcerative colitis	4.88e-05	0.000226	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ALB—ulcerative colitis	4.47e-05	0.000207	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ALB—ulcerative colitis	4.39e-05	0.000203	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PTGS2—ulcerative colitis	3.91e-05	0.000181	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PPARG—ulcerative colitis	3.9e-05	0.000181	CbGpPWpGaD
Epirubicin—ABCC1—Disease—JAK2—ulcerative colitis	3.89e-05	0.00018	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PTGS2—ulcerative colitis	3.84e-05	0.000178	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CD4—ulcerative colitis	3.69e-05	0.000171	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PTGS2—ulcerative colitis	3.66e-05	0.00017	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALB—ulcerative colitis	3.5e-05	0.000162	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—JAK2—ulcerative colitis	3.41e-05	0.000158	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RELA—ulcerative colitis	3.3e-05	0.000153	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCL8—ulcerative colitis	3.11e-05	0.000144	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PTGS2—ulcerative colitis	3.07e-05	0.000142	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL2—ulcerative colitis	2.97e-05	0.000138	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL6—ulcerative colitis	2.96e-05	0.000137	CbGpPWpGaD
Epirubicin—ABCC1—Disease—STAT3—ulcerative colitis	2.86e-05	0.000132	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MMP9—ulcerative colitis	2.81e-05	0.00013	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NFKB1—ulcerative colitis	2.78e-05	0.000129	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TGFB1—ulcerative colitis	2.65e-05	0.000123	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—STAT3—ulcerative colitis	2.5e-05	0.000116	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TGFB1—ulcerative colitis	2.32e-05	0.000108	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IL6—ulcerative colitis	1.99e-05	9.25e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TP53—ulcerative colitis	1.91e-05	8.85e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL6—ulcerative colitis	1.75e-05	8.1e-05	CbGpPWpGaD
